FIG. 2.

(A and B) showed the differences in serum bone turnover markers and related hormones. MRI findings were demonstrated in (C), and blood routine and serum biochemical indicators were shown in (D–F). Statistical differences were expressed as P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***), besides, “ns” meant no significant difference. Parathyroid Hormone (PTH, pg./ml), 25(OH)D (ng/ml), propeptide of type I procollagen (P1NP, ng/ml), b‐C‐terminal telopeptide of type I collagen (β‐CTX, ng/ml), N‐terminal middle segment osteocalcin (N‐MID, ng/ml), alkaline phosphatase (ALP, U/L), acid phosphatase (ACP, U/L), non‐prostatic acid phosphatase (NACP, U/L), prostatic acid phosphatase (PACP, U/L), bone mineral density (BMD, T‐score); Cross‐sectional area (CSA, cm²), vertebral body size (VB, cm²), fatty degeneration ratio (FDR, %), lumbar muscle mass (LMM, cm²), lumbar muscle fat content (LMF, cm²); Red blood cell (RBC, ×10¹²/L), hemoglobin (HB, g/L), white blood cell (WBC, ×10⁹/L). serum albumin (ALB, g/L), total protein (TP, g/L), total cholesterol (TC, mmol/L), triglyceride (TG, mmol/L), high‐density lipoprotein cholesterol (HDL‐C, mmol/L), low‐density lipoprotein cholesterol (LDL‐C, mmol/L), blood glucose (Glu, mmol/L), calcium (Ca, mmol/L), phosphorus (P, mmol/L), magnesium (Mg, mmol/L)